Infectious Diseases and Clinical Microbiology

Doç. Dr. Ramazan Korkusuz

Doctor and researcher Başakşehir Çam ve Sakura Şehir Hastanesi İstanbul
COVID-19HIV Infections
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • HIV Infections 3 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologysaglik.gov.trFrom source
  • InstitutionBaşakşehir Çam ve Sakura Şehir Hastanesisaglik.gov.trFrom source
  • Area of workCOVID-19Extracted from 5 publications · Model version —From source
  • Publications40 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-9988-9596ORCIDFrom source
  • Last synchronised5 November 2026 10:36https://camsakurasehir.saglik.gov.tr/TR-1211776/gorev-yapan-hekimlerimiz.html#ramazan-korkusuzsaglik.gov.tr

Scientific work

Publications on COVID-19

40 publications

  1. Low 1,25-dihydroxyvitamin D levels are associated with severe COVID-19: an observational study in hospitalized patients

    Frontiers in Nutrition, 2026

    DOI 10.3389/fnut.2026.1836021 PMID 42325512 Open-access full textSource: OpenAlex

  2. Herpes zoster as a missed opportunity for HIV diagnosis: a real-world analysis of testing practices

    AIDS Research and Therapy, 2026

    DOI 10.1186/s12981-026-00900-6 PMID 42277865 Open-access full textSource: ORCID

  3. Comparison of candidemia caused by Candida auris and non-auris Candida spp.: a retrospective cohort study on clinical characteristics, risk factors, and antifungal resistance profiles

    BMC Infectious Diseases, 2026

    DOI 10.1186/s12879-026-13666-z PMID 42185810 Open-access full textSource: ORCID

  4. Levofloxacin as a potential substitute for Trimethoprim-Sulfamethoxazole in Stenotrophomonas maltophilia infections: A retrospective cohort study

    Annals of Clinical and Analytical Medicine, 2025

    DOI 10.4328/acam.22890 1 citation (OpenAlex) Open-access full textSource: ORCID

  5. Burkholderia cepacia Salgını: Köpük Sabunun Kontaminasyonu Kaynaklı Hastane Enfeksiyonu

    Mikrobiyoloji Bulteni, 2025

    DOI 10.5578/mb.20250437 PMID 41165103 Open-access full textSource: ORCID

  6. A Novel PCR Panel for Bacterial Detection in Lower Respiratory Tract Infections: A Comparative Study with Culture Results

    Pathogens, 2025

    DOI 10.3390/pathogens14101017 PMID 41156628 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  7. Comparison of Oral Anticoagulant Users with Non-users Admission Laboratory Parameters, Length of Hospital Stay and Outcomes in COVID-19 Infection

    Global Emergency and Critical Care, 2024

    DOI 10.4274/globecc.galenos.2023.86580 Open-access full textSource: OpenAlex

  8. The Relationship of Serum Beta Defensin-2 and Surfactant Protein A and B Levels with the Clinical Course and Prognosis of COVID-19 Infection

    Kafkas Journal of Medical Sciences, 2024

    DOI 10.5505/kjms.2024.33404 Open-access full textSource: OpenAlex

  9. Burkholderia Cepacia Outbreak in Intensive Care Units, Türkiye

    SSRN Electronic Journal, 2024

    DOI 10.2139/ssrn.5033636 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  10. Study Hypothesis: Age, Gender, Presence of Diabetes Mellitus or Hypertension, and Anti-Hypertensive Drugs Are Independent Risk Factors for COVID-19 Mortality

    Acta Clinica Croatica, 2023

    DOI 10.20471/acc.2023.62.03.6 PMID 39310686 Open-access full textSource: ORCID

View all 40 publications